Agios Pharmaceuticals, Inc. - Common Stock, Par Value $0.001 per share (AGIO)

CUSIP: 00847X104

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-1,619,894
Put/Call ratio
126%
SEC-reported price per share
$35.00
Number of holders
206
Value change
-$101,763,130
Number of buys
112
Open additional details 1 more signal available
Number of sells
91
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
59,829,338

Security key

00847X104

Report period

Q3 2020

Institutions

206

Top holders

10

Ownership snapshot

Top reported holders of AGIO - Agios Pharmaceuticals, Inc. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $420,720,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $420.72M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Disclosed position value Top 5
WELLINGTON MANAGEMENT GROUP LLP $420.72M
VANGUARD GROUP INC $307.24M
FMR LLC $300.36M
BlackRock Finance, Inc. $267.76M
Bellevue Group AG $215.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$420,720,000
7,866,877 shares
— 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$307,237,000
5,744,910 shares
— 30 Jun 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$300,361,000
5,616,327 shares
— 30 Jun 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$267,764,000
5,006,831 shares
— 30 Jun 2020
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$215,181,000
4,023,573 shares
— 30 Jun 2020
Capital International Investors
13F
Company
13F
—
denominator unverified
$206,156,000
3,854,832 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
206
Shares
65,869,834
Rows available
206
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
205
Q3 2020 holders
206
Holder diff
1
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .